Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -19,465 | -12,436 | N/A | N/A |
| Depreciation Amortization | 20 | -115 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,486 | 1,034 | N/A | N/A |
| Other Working Capital | 514 | -1,020 | N/A | N/A |
| Other Operating Activity | -1,091 | 27 | 0 | 0 |
| Operating Cash Flow | $-18,536 | $-12,510 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 7,400 | -7,234 | N/A | N/A |
| PPE Investments | -24 | -7 | N/A | N/A |
| Investing Cash Flow | $7,376 | $-7,241 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 87 | 26 | N/A | N/A |
| Other Financing Activity | 47,185 | 24,960 | 0 | 0 |
| Financing Cash Flow | $47,272 | $24,986 | $N/A | $N/A |
| Beginning Cash Position | 17,501 | 12,266 | N/A | N/A |
| End Cash Position | 53,613 | 17,501 | N/A | N/A |
| Net Cash Flow | $36,112 | $5,235 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -18,536 | -12,510 | N/A | N/A |
| Capital Expenditure | -24 | -7 | N/A | N/A |
| Free Cash Flow | -18,560 | -12,517 | 0 | 0 |